{
  "id": 15943534,
  "title": "EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen",
  "url": "https://urgent.news/2026/10/21/eqt-nears-9-6-billion-deal-for-molecular-testing-firm-qiagen",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T19:38:02.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/articles/2026-10-21/eqt-nears-9-6-billion-deal-for-molecular-testing-firm-qiagen"
  },
  "original_language": "en",
  "account": null,
  "summary": "EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}